CENTRAL TIME ZONE

During the webinar, Dr. Gregory Aubert, VP of Clinical Development at Lexeo, and Dr. Theresa Zesiewicz, Director of the Ataxia Research Center at the University of South Florida, will share the latest updates from Lexeo’s gene therapy program, including information about the SUNRISE-FA 2 investigational gene therapy trial, a late-stage clinical trial to evaluate whether LX2006 may improve heart function and limit the progression of Friedreich ataxia cardiomyopathy (FA-CM).    This webinar is intended for people living with FA and their families. Please note: This webinar is intended for general educational purposes. Presenters are unable to provide individualized medical advice or address personal medical concerns during the session. We encourage you to discuss questions specific to your health or care with your healthcare provider.

Please note: This webinar is intended for general educational purposes. Presenters are unable to provide individualized medical advice or address personal medical concerns during the session. We encourage you to discuss questions specific to your health or care with your healthcare provider.